Amgen Obesity Drug Falls Short of Efficacy Expectations in Trial, Mizuho Says; Shares Decline

MT Newswires16:00 ET

H.C. Wainwright Maintains Viking Therapeutics(VKTX.US) With Buy Rating, Maintains Target Price $102

Moomoo News12:32 ET · Ratings

Express News | HC Wainwright & Co. Reiterates Buy on Viking Therapeutics, Maintains $102 Price Target

Benzinga11:47 ET

Viking Therapeutics' VK2735: A Leading Contender in Obesity Treatment With Strong Performance and Safety Profile

TipRanks11:45 ET

Press Release: Viking Mergers & Acquisitions Announces Key Promotions in Florida Division, Showcasing Internal Growth-Focused Culture and Leadership

Dow Jones11:34 ET

Viking Mergers & Acquisitions Announces Key Promotions in Florida Division, Showcasing Internal Growth-Focused Culture and Leadership

PR Newswire11:33 ET